Longitudinal study with positron emission tomography using [18F]PI-2620 in primary tauopathies. Proof-of-concept study

2025-522826-11-00 Protocol BIS-FPI-2025-01 Phase I and Phase II (Integrated) - Other Ongoing, recruiting

Start 6 Nov 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol BIS-FPI-2025-01

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - Other
Status Ongoing, recruiting
Participants planned 64
Countries 1
Sites 1

Corticobasal syndrome (CBS)

Key facts

Sponsor
ZRO Imaging AB
Participant type
Patients, Healthy volunteers
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Nervous System Diseases [C10], Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
Trial duration
6 Nov 2025 → ongoing
Decision date (initial)
2025-11-03
Transition trial
No
Low-intervention
No
Rare-disease indication
Yes
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Corticobasal syndrome (CBS)

VersionLevelCodeTermSystem organ class
21.1 PT 10036813 Progressive supranuclear palsy 100000004852
21.1 PT 10068968 Frontotemporal dementia 100000004852
20.1 LLT 10036223 Positron emission tomography 10022891
20.0 PT 10078208 Corticobasal degeneration 100000004852

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

ZRO Imaging AB

Sponsor organisation
ZRO Imaging AB
Address
Mardgatan 20, Alvsborg Alvsborg
City
Vastra Frolunda
Postcode
426 71
Country
Sweden

Scientific contact point

Organisation
ZRO Imaging AB
Contact name
Dr. Alexis Moscoso

Public contact point

Organisation
ZRO Imaging AB
Contact name
Dr. Alexis Moscoso

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 64 1
Rest of world 0

Investigational sites

Spain

1 site · Ongoing, recruiting
Complexo Hospitalario Universitario De Santiago
Medicina Nuclear, Calle Choupana Da S/n, 15706, Santiago De Compostela

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2025-11-06 2025-11-11

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-07-14 Spain Acceptable
2025-11-03
2025-11-03
2 SUBSTANTIAL MODIFICATION SM-1 2025-12-08 Spain Acceptable
2026-04-06
2026-04-13